Stock 4507 SHIONOGI & CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Shionogi & Co., Ltd.

Equities

4507

JP3347200002

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-07-09 am EDT 		5-day change 1st Jan Change
6,376 JPY +1.25% Intraday chart for Shionogi & Co., Ltd. +2.38% -6.21%
Jun. 25 Japanese Shares Close Higher as Officials Address Yen Volatility Concerns MT
Jun. 25 Shionogi & Co Introduces Covgoze Vaccine for Covid-19 in Japan MT

Business Summary

Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:

- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;

- OTC products: analgesic products, vitamins and tonics, etc.;

- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.

Number of employees: 4,959

Sales per Business

JPY in Million2023Weight2024Weight Delta
Pharmaceutical
100.0 %
426,684 100.0 % 410,073 100.0 % -3.89%

Sales per region

JPY in Million2023Weight2024Weight Delta
United Kingdom
49.1 %
174,706 40.9 % 201,288 49.1 % +15.22%
Japan
37.9 %
207,777 48.7 % 155,278 37.9 % -25.27%
United States
4.4 %
16,247 3.8 % 18,031 4.4 % +10.98%
Other
4.3 %
17,670 4.1 % 17,766 4.3 % +0.54%
Europe
4.3 %
10,276 2.4 % 17,702 4.3 % +72.27%
North America
0.0 %
6 0.0 % 5 0.0 % -16.67%

Managers

Managers TitleAgeSince
Isao Teshirogi CEO
 Chief Executive Officer 64 82-03-31
Yuji Hosogai DFI
 Director of Finance/CFO - -
Yasuetsu Imune CTO
 Chief Tech/Sci/R&D Officer - -
John Keller CTO
 Chief Tech/Sci/R&D Officer - -
Takuko Sawada BRD
 Director/Board Member 69 77-03-31
Yoshinori Yurugi PRN
 Corporate Officer/Principal - -
Aki Ikehata LAW
 General Counsel - -
Hirofumi Nagadome HRO
 Human Resources Officer - -
Harumi Shimai SAM
 Sales & Marketing - -
Takeshi Shiota PRN
 Corporate Officer/Principal - 14-12-31

Members of the board

Members of the board TitleAgeSince
Hiroshi Ozaki BRD
 Director/Board Member 74 19-05-31
Isao Teshirogi CEO
 Chief Executive Officer 64 82-03-31
Takuko Sawada BRD
 Director/Board Member 69 77-03-31
Keiichi Ando BRD
 Director/Board Member 72 16-05-31
Fumi Takatsuki BRD
 Director/Board Member 49 20-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 300,385,201 258,309,303 ( 85.99 %) 23,894,588 ( 7.955 %) 85.99 %

Shareholders

NameEquities%Valuation
Sumitomo Life Insurance Co.
6.274 %
18,604,000 6.274 % 726 M ¥
Nomura Asset Management Co., Ltd.
6.206 %
18,403,900 6.206 % 718 M ¥
SHIONOGI & CO., LTD.
3.390 %
10,052,488 3.390 % 392 M ¥
Sumitomo Mitsui Banking Pension Fund
3.199 %
9,485,000 3.199 % 370 M ¥
Nikko Asset Management Co., Ltd.
3.014 %
8,938,400 3.014 % 349 M ¥
BlackRock Fund Advisors
3.012 %
8,931,960 3.012 % 349 M ¥
Nippon Life Insurance Co.
2.836 %
8,409,000 2.836 % 328 M ¥
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.
2.143 %
6,356,000 2.143 % 248 M ¥
BlackRock Japan Co. Ltd.
2.075 %
6,154,600 2.075 % 240 M ¥
Mitsubishi UFJ Asset Management Co., Ltd.
1.527 %
4,528,400 1.527 % 177 M ¥
NameEquities%Valuation
Todd Asset Management LLC
0.1641 %
1,946,777 0.1641 % 19 M ¥
Ativo Capital Management LLC
0.008847 %
104,946 0.008847 % 1 M ¥
RhumbLine Advisers LP
0.003064 %
36,350 0.003064 % 354 594 ¥
PNC Investments LLC
0.000983 %
11,661 0.000983 % 113 753 ¥
GAMMA Investing LLC
0.000124 %
1,474 0.000124 % 14 379 ¥
Operose Advisors LLC
0.000044 %
518 0.000044 % 5 053 ¥

Holdings

NameEquities%Valuation
SHIONOGI & CO., LTD.
3.39%
 10,052,488 3.39% 392,263,261 $
SUMITOMO MITSUI FINANCIAL GROUP, INC.
0.12%
 1,643,810 0.12% 109,597,547 $
TOHO HOLDINGS CO., LTD.
4.58%
 3,500,000 4.58% 91,470,855 $
SUZUKEN CO., LTD.
2.13%
 1,656,696 2.13% 50,351,779 $
MEDIPAL HOLDINGS CORPORATION
0.57%
 1,271,605 0.57% 19,351,539 $
KISSEI PHARMACEUTICAL CO., LTD.
1.85%
 914,000 1.85% 18,523,188 $
KANEKA CORPORATION
0.40%
 266,600 0.40% 7,002,270 $
SUMITOMO MITSUI TRUST HOLDINGS, INC.
0.03%
 210,420 0.03% 4,800,705 $
ONO PHARMACEUTICAL CO., LTD.
0.07%
 344,095 0.07% 4,698,524 $
STEMRIM
2.93%
 1,800,000 2.93% 4,576,644 $

Company contact information

Shionogi & Co., Ltd.

3-1-8 Dosho-machi Chuo-Ku

541-0045, Osaka

+81 6 6202 2161

http://www.shionogi.co.jp
address Shionogi & Co., Ltd.(4507)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per region

Ratings for Shionogi & Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
6,297 JPY
Average target price
7,575 JPY
Spread / Average Target
+20.29%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
SHIONOGI & CO., LTD. Stock Shionogi & Co., Ltd.
-6.21% 11.11B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+58.76% 827B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+38.82% 634B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.38% 350B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.41% 319B
ABBVIE INC. Stock AbbVie Inc.
+8.36% 294B
ASTRAZENECA PLC Stock AstraZeneca PLC
+12.96% 240B
NOVARTIS AG Stock Novartis AG
+14.72% 221B
ROCHE HOLDING AG Stock Roche Holding AG
0.00% 219B
AMGEN INC. Stock Amgen Inc.
+8.27% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4507 Stock
  4. Company Shionogi & Co., Ltd.